Genetic Variants Linked to Carpal Tunnel Syndrome Risk

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on blood testing & biomarkers. Browse all Blood Testing & Biomarkers education

Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy, affecting an estimated 3 to 6 percent of adults. It develops when the median nerve is compressed as it passes through the carpal tunnel at the wrist. Repetitive strain gets most of the attention, but large genetic studies show a real inherited component — and one gene family, the ADAMTS group, keeps surfacing as the strongest signal.

What happens in carpal tunnel syndrome

The carpal tunnel is a narrow passage of bone and ligament at the base of the palm. The median nerve and nine tendons share that tight space. When the tunnel narrows or its contents swell, the nerve is squeezed. The result is tingling, numbness, and weakness in the thumb, index, and middle fingers — classically worse at night. Untreated, compression can cause lasting weakness and muscle wasting at the base of the thumb, which is why persistent symptoms deserve a clinical evaluation rather than watchful waiting.

Is carpal tunnel syndrome genetic?

Family and twin studies have long hinted that CTS runs in families, with heritability estimates ranging roughly from 0.3 to 0.5. The clearest evidence arrived in 2019, when a UK Biobank genome-wide association study by Wiberg and colleagues analyzed more than 12,000 cases and identified 16 genomic regions associated with CTS risk. Several of the strongest signals sat in or near genes of the ADAMTS family — enzymes that shape the connective tissue surrounding the median nerve. That points to biology, not just keyboard time, as part of the story.

ADAMTS17 and connective-tissue remodeling

Among those hits, ADAMTS17 stands out as one of the most biologically plausible. ADAMTS17 encodes an enzyme that helps organize the extracellular matrix — the collagen-and-protein scaffolding that gives tendons and ligaments their structure. Variants in this gene are also linked to differences in height and connective-tissue architecture. In the wrist, subtle differences in how that matrix is built and maintained may change how much room the median nerve has to move. Related genes such as ADAMTS10 and ADAMTS8 showed up in the same analysis, reinforcing that matrix remodeling is a recurring theme. Importantly, these variants are risk-modifying, not deterministic: carrying them raises the odds a little, but does not guarantee CTS.

COMT, pain sensitivity, and metabolic risk factors

Genetics also shapes how carpal tunnel syndrome is experienced. The COMT gene, and its well-studied Val158Met variant (rs4680), governs how quickly the body breaks down catecholamines like dopamine and norepinephrine. Because that chemistry feeds into pain processing, COMT genotype has been associated with differences in pain sensitivity and reporting across many conditions — which may influence how severe CTS feels, even when nerve compression is similar. Body weight matters too: obesity is one of the strongest modifiable risk factors for CTS, and variants in FTO influence appetite and body-mass regulation, an indirect genetic route to risk. Diabetes, thyroid dysfunction, and pregnancy round out the metabolic and hormonal contributors.

Where pathway-level genetics fits in

No single gene "causes" carpal tunnel syndrome, and no consumer genetic test diagnoses it. What genetics offers is context — a view of the inflammatory, metabolic, and connective-tissue pathways that shape your baseline biology. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights across systems including inflammation and metabolism. It does not test for CTS or predict who will develop it; it provides pathway-level information you can bring to a qualified provider. As the guiding principle goes, PlexusDx tells you about your biology — it does not tell you what to put in your body.

What to do with the information

If you have persistent numbness, tingling, or hand weakness, see a healthcare provider — early evaluation protects the nerve. Evidence-based general strategies discussed in the literature include ergonomic adjustments, wrist positioning, and managing weight and blood sugar. Genetics is a guide, not a guarantee: knowing your predispositions can sharpen the conversation with your clinician, but the diagnosis and any care plan belong with them.

Frequently Asked Questions

Is carpal tunnel syndrome inherited?

Partly. Twin and family studies estimate heritability between about 0.3 and 0.5, meaning genetics accounts for a meaningful share of risk alongside factors like repetitive strain, body weight, and pregnancy. Inheritance raises your odds but does not make carpal tunnel syndrome inevitable, and lifestyle factors remain significant.

Which gene is most linked to carpal tunnel syndrome?

ADAMTS17 is among the strongest and most biologically plausible signals identified in the 2019 UK Biobank genome-wide study. It shapes the extracellular matrix that structures wrist connective tissue. Related ADAMTS-family genes also appeared, pointing to connective-tissue remodeling as a recurring genetic theme in carpal tunnel risk.

Can a genetic test tell me if I will get carpal tunnel syndrome?

No. Genetic testing cannot diagnose or predict carpal tunnel syndrome. It offers pathway-level context about inflammatory, metabolic, and connective-tissue biology that you can discuss with a qualified provider. Diagnosis relies on clinical examination and, when needed, nerve conduction studies performed by a healthcare professional.

Want to understand the genetic pathways behind your wellness? Explore the Precision Peptide Genetic Test to see how your DNA influences inflammation, metabolism, and peptide-related biology — then bring those insights to your healthcare provider.

The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

This article is part of the PlexusDx Education Hub. Browse all Blood Testing & Biomarkers education